🔗 Share this article Social Media Influencers Fueling Unofficial Market for Unapproved Slimming Drug A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings. Experimental Drug Gaining Popularity Online The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to message these accounts privately for source information, while also receiving promotional offers. Active Trade on Messaging Platforms Additionally, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for purchases. Understanding The Experimental Drug Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic. Medical Professionals Express Worries Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of unknown origin. Some experts said the demand for retatrutide could be connected to the increasing cost of approved weight loss products such as Mounjaro. Legal Status and Enforcement Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations. Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking penalties, legal action or prison. Service Reaction and Material Removal According to the social media company, the service has removed problematic material and banned associated keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies. Digital Marketplace Activities Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of slimming results, glowing testimonials and detailed guides for preparing or administering at residence. Within moments of entering one community, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience. Product Information and Costs Inside these groups, messages show black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.” Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When asked how long a pen should last, vendors give contradictory answers ranging from a few weeks to “depends on your body”. Service Moderation and Security Measures A representative for Telegram said it actively moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”. Medical Expert Warnings “People are injecting materials they can’t verify. Although the science behind retatrutide is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U. Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said. Her team has already encountered individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be impure or improperly measured.” Manufacturer Position A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject patients to potentially serious medical dangers”.